|
🐜
|
The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
14 auth.
João J. Oliveira,
Sarah Karrar,
Daniel B. Rainbow,
C. Pinder,
Pamela Clarke,
A. Rubio García,
O. Al-Assar,
K. Burling,
Sian Morris,
R. Stratton,
...
T. Vyse,
L. Wicker,
J. Todd,
R. Ferreira
|
5 |
2018 |
5
🐜
|
|
🐜
|
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
25 auth.
Bodoor Yaseen,
H. Lopez,
Z. Taki,
S. Zafar,
H. Rosario,
B. Abdi,
S. Vigneswaran,
F. Xing,
N. Arumalla,
S. Black,
S. Ahmad,
Kimti Kumar,
Rabia Gul,
Laura Scolamiero,
Sian Morris,
...
A. Bowman,
Anna Stainer,
A. Rice,
C. Stock,
E. Renzoni,
C. Denton,
C. Venturini,
Max Brown,
S. O’Reilly,
R. Stratton
|
5 |
2020 |
5
🐜
|
|
🐜
|
OP0182 SYNTHETIC PEPTIDES TARGETING CD206 INHIBIT PATHOGENIC MACROPHAGES IN SYSTEMIC SCLEROSIS
13 auth.
H. Lopez,
Kimti Kumar,
George Martin,
Jesse Jaynes,
J. Stanway,
B. Abdi,
N. Arumalla,
Sarah Karrar,
Sian Morris,
C. Denton,
...
D. Abraham,
Shiwen Xu,
R. Stratton
|
0 |
2019 |
0
🐜
|
